A detailed history of Alliancebernstein L.P. transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 342,540 shares of PACB stock, worth $674,803. This represents 0.0% of its overall portfolio holdings.

Number of Shares
342,540
Previous 342,540 -0.0%
Holding current value
$674,803
Previous $469,000 24.09%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$1.36 - $3.65 $97,661 - $262,106
71,810 Added 26.52%
342,540 $469,000
Q4 2023

Feb 14, 2024

BUY
$5.97 - $10.36 $41,193 - $71,484
6,900 Added 2.62%
270,730 $2.66 Million
Q3 2023

Nov 14, 2023

SELL
$8.23 - $13.93 $302,041 - $511,231
-36,700 Reduced 12.21%
263,830 $2.2 Million
Q2 2023

Aug 15, 2023

BUY
$9.97 - $14.05 $710,163 - $1 Million
71,230 Added 31.06%
300,530 $4 Million
Q1 2023

May 15, 2023

SELL
$7.94 - $12.02 $79,400 - $120,200
-10,000 Reduced 4.18%
229,300 $2.66 Million
Q4 2022

Feb 14, 2023

SELL
$5.67 - $11.2 $24,948 - $49,280
-4,400 Reduced 1.81%
239,300 $1.96 Million
Q2 2022

Aug 15, 2022

SELL
$4.02 - $10.43 $4,421 - $11,473
-1,100 Reduced 0.45%
243,700 $1.08 Million
Q1 2022

May 13, 2022

BUY
$8.43 - $20.9 $5,058 - $12,540
600 Added 0.25%
244,800 $2.23 Million
Q3 2021

Nov 10, 2021

SELL
$24.86 - $35.02 $34,804 - $49,028
-1,400 Reduced 0.57%
244,200 $6.24 Million
Q2 2021

Jul 30, 2021

BUY
$22.3 - $36.02 $142,720 - $230,528
6,400 Added 2.68%
245,600 $8.59 Million
Q1 2021

May 06, 2021

SELL
$26.38 - $51.15 $456,374 - $884,895
-17,300 Reduced 6.74%
239,200 $7.97 Million
Q4 2020

Feb 08, 2021

BUY
$10.5 - $28.5 $321,300 - $872,100
30,600 Added 13.55%
256,500 $6.65 Million
Q3 2020

Nov 12, 2020

BUY
$3.61 - $9.87 $106,856 - $292,152
29,600 Added 15.08%
225,900 $2.23 Million
Q1 2020

May 14, 2020

SELL
$2.36 - $5.26 $2.12 Million - $4.73 Million
-898,828 Reduced 82.08%
196,300 $601,000
Q4 2019

Feb 18, 2020

BUY
$4.6 - $5.57 $1.34 Million - $1.62 Million
291,395 Added 36.26%
1,095,128 $5.63 Million
Q3 2019

Nov 14, 2019

BUY
$4.99 - $6.16 $275,323 - $339,878
55,175 Added 7.37%
803,733 $4.15 Million
Q2 2019

Aug 14, 2019

BUY
$5.92 - $7.41 $2.09 Million - $2.62 Million
353,179 Added 89.33%
748,558 $4.53 Million
Q1 2019

May 14, 2019

SELL
$6.8 - $7.4 $350,050 - $380,937
-51,478 Reduced 11.52%
395,379 $2.86 Million
Q4 2018

Feb 13, 2019

BUY
$3.99 - $7.82 $1.22 Million - $2.39 Million
306,157 Added 217.6%
446,857 $3.31 Million
Q2 2018

Aug 13, 2018

BUY
$2.11 - $3.92 $52,117 - $96,824
24,700 Added 21.29%
140,700 $499,000
Q1 2018

May 14, 2018

BUY
$2.05 - $3.23 $26,649 - $41,990
13,000 Added 12.62%
116,000 $238,000
Q3 2017

Nov 13, 2017

BUY
$3.2 - $5.57 $329,600 - $573,710
103,000
103,000 $541,000

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $443M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Alliancebernstein L.P. Portfolio

Follow Alliancebernstein L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.